With NAN now in the AX200, it may not fit some fund managers' strategies and they may be exiting? The SP may be a little bumpy in the very short term but I wouldn't be too worried about it. @pweekes78 , if it makes you feel any better, I got in above $3 and believe NAN is at its very early stage of a high growth future.
The upside potential is huge with the expansion of Trophon sales in the European market, as well as Japan and other geographies potentially contributing in FY18. "We are geared up to double sales in half the time", said Michael K. during the last quarterly conf call, so no constraints in ramping up sales to meet increased trophon demand.
Second gen Trophon and new product(s) are in the pipeline. MK said, they are working on some exciting products and details will be announced when the products are commercially ready.
Totally agree with @chillam , this could be another CSL or Cochlear.
NAN - Market Leader & ASX200 Leader!, page-16
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NAN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$3.62 |
Change
-0.080(2.16%) |
Mkt cap ! $1.098B | |||
| Open | High | Low | Value | Volume |
| $3.68 | $3.71 | $3.62 | $830.3K | 227.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4025 | $3.62 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.65 | 1310 | 3 |
View Market Depth
| Last trade - 16.10pm 08/10/2024 (20 minute delay) ? |
| NAN (ASX) Chart |